A002 – Genetics and systems biology

Research objectives

  • Identification of genetic biomarkers of disease susceptibility and prognosis.
  • Improved ability to stratify populations to move towards personalised therapies and reduced side effects.
  • Optimisation of genetic diagnosis techniques: advanced technology and standardisation.

Research groups

C005 – Genetics

C005 – Genetics

C009 – Translational Research in Digestive System Diseases

C009 – Translational Research in Digestive System Diseases

C026 – BIOFARMA

C026 – BIOFARMA

C041 – Genetics in Cancer and Rare Diseases

C041 – Genetics in Cancer and Rare Diseases

E012 – Comparative Genomics of Human Parasites

E012 – Comparative Genomics of Human Parasites

E020 – Genética Psiquiátrica

E020 – Genética Psiquiátrica

E020 – Psychiatric Genetics

E020 – Psychiatric Genetics

E021 – Genetics and Developmental Biology of Kidney Diseases

E021 – Genetics and Developmental Biology of Kidney Diseases

E035 – Genetics of Gastrointestinal Tumours

E035 – Genetics of Gastrointestinal Tumours

E036 – Stem Cells and Human Diseases

E036 – Stem Cells and Human Diseases

E047 – Cancer Genetics and Epidemiology Group

E047 – Cancer Genetics and Epidemiology Group

E054 – Epitranscriptomics and aging

E054 – Epitranscriptomics and aging

E055 – Cancer predisposition and biomarkers

E055 – Cancer predisposition and biomarkers

E059 – MitoPhenomics

E059 – MitoPhenomics

E061 – Pharmacogenomics and drug discovery (GenDeM)

E061 – Pharmacogenomics and drug discovery (GenDeM)

E068 – Inmunogenetics

E068 – Inmunogenetics

E071 – Cognition, Gender and Neurodevelopment (CogniGeND)

E071 – Cognition, Gender and Neurodevelopment (CogniGeND)

Area leader

Genética – Ángel Carracedo

Ángel Carracedo Álvarez

Catedrático de Medicina Legal de la Universidad de Santiago (USC) desde 1989. Director de la Fundación Pública Galega de Medicina Xenómica (Servizo Galego de Saúde-Xunta de Galicia) desde 1997, Director del Centro Nacional de Genotipado-ISCIII desde 2002.
angel.carracedo@usc.es
(+34) 981 951 490
https://orcid.org/0000-0003-1085-8986
+ INFO

Area co-leader

A002 subcoordinadora – Mabel Loza

Mabel Loza García

Doctora en Farmacia por la Universidad de Santiago de Compostela. Catedrática de Farmacología de la USC y líder del grupo de investigación BioFarma.
biofarma.group@usc.es
(+34) 881 815 459
http://orcid.org/0000-0003-4730-0863
+ INFO

Privacy overview

This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.